These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38488495)

  • 21. Progression of human monkeypox infection despite tecovirimat in an immunocompromised adult.
    Dammann F; Raja M; Camargo JF
    Transpl Infect Dis; 2023 Feb; 25(1):e14022. PubMed ID: 36714983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug Interactions Between Psychotropic Medications and Treatment of Mpox (tecovirimat and cidofovir).
    Mansuri Z; Shah B; Yadav G; Kainth T; Kochhar H; Srinivas S; Kamil SH; Bachu A; Reddy A
    Prim Care Companion CNS Disord; 2024 Feb; 26(1):. PubMed ID: 38382079
    [No Abstract]   [Full Text] [Related]  

  • 23. Repurposing of the antibiotic nitroxoline for the treatment of mpox.
    Bojkova D; Zöller N; Tietgen M; Steinhorst K; Bechtel M; Rothenburger T; Kandler JD; Schneider J; Corman VM; Ciesek S; Rabenau HF; Wass MN; Kippenberger S; Göttig S; Michaelis M; Cinatl J
    J Med Virol; 2023 Mar; 95(3):e28652. PubMed ID: 36897017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges in Managing Treatment-Resistant Mpox Complicated by Severe Superinfection.
    Fortier JC; Marsalisi C; Cordova E; Guo HJ; Verdecia J
    Open Forum Infect Dis; 2024 Apr; 11(4):ofae138. PubMed ID: 38651138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human monkeypox virus infection in an immunocompromised man: trial with tecovirimat.
    Hernandez LE; Jadoo A; Kirsner RS
    Lancet; 2022 Sep; 400(10355):e8. PubMed ID: 36088950
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review.
    Shamim MA; Padhi BK; Satapathy P; Veeramachaneni SD; Chatterjee C; Tripathy S; Akhtar N; Pradhan A; Dwivedi P; Mohanty A; Rodriguez-Morales AJ; Sah R; Al-Tammemi AB; Al-Tawfiq JA; Nowrouzi-Kia B; Chattu VK
    Int J Infect Dis; 2023 Feb; 127():150-161. PubMed ID: 36470502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (Smallpox).
    Mucker EM; Goff AJ; Shamblin JD; Grosenbach DW; Damon IK; Mehal JM; Holman RC; Carroll D; Gallardo N; Olson VA; Clemmons CJ; Hudson P; Hruby DE
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6246-53. PubMed ID: 24100494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A severe monkeypox infection in a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcome.
    Viguier C; de Kermel T; Boumaza X; Benmedjahed NS; Izopet J; Pasquier C; Delobel P; Mansuy JM; Martin-Blondel G
    Int J Infect Dis; 2022 Dec; 125():135-137. PubMed ID: 36397606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early use of tecovirimat in a young man with severe mpox skin lesions: a case report.
    Iannone V; Ciccullo A; Farinacci D; Borghetti A; Visconti E; Marchetti S; Sanguinetti M; Tamburrini E; Di Giambenedetto S
    J Med Virol; 2023 Feb; 95(2):e28528. PubMed ID: 36695663
    [No Abstract]   [Full Text] [Related]  

  • 30. Monkeypox treatment: Current evidence and future perspectives.
    Khani E; Afsharirad B; Entezari-Maleki T
    J Med Virol; 2023 Jan; 95(1):e28229. PubMed ID: 36253931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tecovirimat Treatment of People With HIV During the 2022 Mpox Outbreak : A Retrospective Cohort Study.
    McLean J; Stoeckle K; Huang S; Berardi J; Gray B; Glesby MJ; Zucker J
    Ann Intern Med; 2023 May; 176(5):642-648. PubMed ID: 37126820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of Korea.
    Kim HM; Lee N; Kim MS; Kang C; Chung YS
    Virol J; 2020 Jul; 17(1):94. PubMed ID: 32631440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection.
    Berhanu A; Prigge JT; Silvera PM; Honeychurch KM; Hruby DE; Grosenbach DW
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4296-300. PubMed ID: 25896687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case Report and Literature Review of Occupational Transmission of Monkeypox Virus to Healthcare Workers, South Korea.
    Choi Y; Jeon EB; Kim T; Choi SJ; Moon SM; Song KH; Kim HB; Kim ES
    Emerg Infect Dis; 2023 May; 29(5):997-1001. PubMed ID: 36856759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fragment-Based Approaches Identified Tecovirimat-Competitive Novel Drug Candidate for Targeting the F13 Protein of the Monkeypox Virus.
    Ali Y; Imtiaz H; Tahir MM; Gul F; Saddozai UAK; Ur Rehman A; Ren ZG; Khattak S; Ji XY
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mpox Genital Lesions: A Large Single-center Experience With Intermediate Follow-up.
    Lee J; McLean J; Zucker J; Brandes S; Joice G
    J Urol; 2023 Sep; 210(3):510-516. PubMed ID: 37294043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques.
    Russo AT; Grosenbach DW; Brasel TL; Baker RO; Cawthon AG; Reynolds E; Bailey T; Kuehl PJ; Sugita V; Agans K; Hruby DE
    J Infect Dis; 2018 Sep; 218(9):1490-1499. PubMed ID: 29982575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Features of Mpox Patients in Korea: A Multicenter Retrospective Study.
    Lim SY; Jo HJ; Lee SY; Ahn M; Kim Y; Jeon J; Kim ES; Chin B; Choi JP; Kim NJ
    J Korean Med Sci; 2024 Jan; 39(4):e19. PubMed ID: 38288533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral Tecovirimat for the Treatment of Smallpox.
    Grosenbach DW; Honeychurch K; Rose EA; Chinsangaram J; Frimm A; Maiti B; Lovejoy C; Meara I; Long P; Hruby DE
    N Engl J Med; 2018 Jul; 379(1):44-53. PubMed ID: 29972742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tecovirimat for Monkeypox in Central African Republic under Expanded Access.
    Mbrenga F; Nakouné E; Malaka C; Bourner J; Dunning J; Vernet G; Horby P; Olliaro P
    N Engl J Med; 2022 Dec; 387(24):2294-2295. PubMed ID: 36449745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.